CD5L, a macrophage-derived glycoprotein, increased significantly in chronic hepatitis (CHB and CHC) and cirrhosis (ALC and NALC), modulating inflammation and lipid metabolism [13,62,63,64]. This evidence concerns the gene CD5L and chronic hepatitis.